Neuregulin-Induced ErbB3 Downregulation Is Mediated by a Protein Stability Cascade Involving the E3 Ubiquitin Ligase Nrdp1
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms underlying epidermal growth factor (EGF) receptor tyrosine kinase down-regulation in response to growth factor binding are coming into focus and involve cbl-mediated receptor ubiquitination followed by lysosomal degradation. However, mechanisms underlying the ligand-stimulated degradation of the related receptor tyrosine kinases of the ErbB family do not involve cbl and remain unexplored. Previous studies have demonstrated that the E3 ubiquitin ligase Nrdp1 contributes to the maintenance of steady-state ErbB3 levels by mediating its growth factor-independent degradation. Here we demonstrate that treatment of cells with the ErbB3 ligand neuregulin-1 (NRG1) stabilizes the deubiquitinating enzyme USP8, which in turn stabilizes Nrdp1. The catalytic activity of USP8 is required for NRG1-induced Nrdp1 stabilization. We provide evidence that Akt-mediated phosphorylation of USP8 threonine residue T907 contributes to USP8 stability. Finally, we demonstrate that Nrdp1 or USP8 knockdown suppresses NRG1-induced ErbB3 ubiquitination and degradation in MCF7 breast cancer cells. We conclude that an NRG1-induced protein stability cascade involving USP8 and Nrdp1 mediates the down-regulation of ErbB3. Our observations raise the possibility that the ligand-induced augmentation of pathways involved in the maintenance of basal levels of receptor tyrosine kinases can contribute to ligand-stimulated down-regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the rhodanese-like domain (Rhod) of USP8 is known to bind the E3 ligase, Nrdp1, and in so doing indirectly influences the degradation of Erb-B3 (33,36,37).”
From Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8·STAM Complex (2010) · cites this paper as [36]
In the citing paper
“Ubiquitin-mediated protein degradation has been shown to regulate ErbB3 (Cao, 2007), but this process is on the order of several hours, which is too slow to account for the observed dynamics of ErbB3 phosphorylation.”
From Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data (2009) · cites this paper as Cao, 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“For example, amplification of the erbB2 gene is observed in 25 to 30% of breast cancer patients, and overexpression of the product correlates with an earlier relapse and poor prognosis (46, 47).”
BackgroundStudies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Olayioye, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,434
Receptor downregulation and multivesicular-body sorting
Katzmann, D. J., Odorizzi, G., & Emr, S. D. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm973 · Cited by 1,201
Levkowitz, G., Waterman, H., Ettenberg, S. A., Katz, M., Tsygankov, A. Y., Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80231-2 · Cited by 1,001
Holbro, T., Beerli, R. R., Maurer, F., Koziczak, M., Barbas, C. F., & Hynes, N. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1537685100 · Cited by 950
Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation
Haglund, K., Sigismund, S., Polo, S., Szymkiewicz, I., Di Fiore, P. P., & Dikic, I. (2003) · Nature Cell Biology · doi:10.1038/ncb983 · Cited by 715
Alroy, I., & Yarden, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00412-2 · Cited by 714
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A., & Carraway, K. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8132 · Cited by 698 · cited 1×
“Since ErbB3 lacks intrinsic tyrosine kinase activity (16) and no diffusible ligand that binds to ErbB2 has been described, these two receptors must necessarily collaborate in propagating signals in response to growth factors such as the ErbB3 ligand neuregulin-1 (NRG1) ( 9, 48).”
BackgroundSelf-citationCoexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
Sliwkowski, M. X., Schaefer, G., Akita, R. W., Lofgren, J. A., Fitzpatrick, V. D., Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, R. L., & Carraway, K. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36676-0 · Cited by 643
Self-citation
Research works printed but not linked: 1
- 42. Riese, D. J., II, and D. F. Stern. 1998. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20: 41-48. · DOI · Paper page
Cited by
Breaking the chains: structure and function of the deubiquitinases
Komander, D., Clague, M. J., & Urbé, S. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2731 · Cited by 1,969
Endocytosis and intracellular trafficking of ErbBs
Sorkin, A., & Goh, L. K. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.029 · Cited by 756
Endocytosis of Receptor Tyrosine Kinases
Goh, L. K., & Sorkin, A. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a017459 · Cited by 461
Deubiquitinases in cancer: new functions and therapeutic options
Fraile, J. M., Quesada, V, Rodríguez, D., Freije, J. M. P., & López-Otín, C. (2012) · Oncogene · doi:10.1038/onc.2011.443 · Cited by 453
Chen, W. W., Schoeberl, B., Jasper, P. J., Niepel, M., Nielsen, U. B., Lauffenburger, D. A., & Sorger, P. K. (2009) · Molecular Systems Biology · doi:10.1038/msb.2008.74 · Cited by 391
Deubiquitinase inhibition as a cancer therapeutic strategy
D'Arcy, P., Wang, X., & Linder, S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.002 · Cited by 310
The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon
Wang, C., Chen, T., Zhang, J., Yang, M., Li, N., Xu, X., & Cao, X. (2009) · Nature Immunology · doi:10.1038/ni.1742 · Cited by 317
Ubiquitination and the Regulation of Membrane Proteins
Foot, N., Henshall, T., & Kumar, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00012.2016 · Cited by 262
The regulatory crosstalk between kinases and proteases in cancer
López-Otín, C., & Hunter, T. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2823 · Cited by 244
Miranda, M., & Sorkin, A. (2007) · Molecular Interventions · doi:10.1124/mi.7.3.7 · Cited by 205
Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer
Roepstorff, K., Grøvdal, L., Grandal, M., Lerdrup, M., & van Deurs, B. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0401-3 · Cited by 202
SnapShot: EGFR Signaling Pathway
Yarden, Y., & Shilo, B.-Z. (2007) · Cell · doi:10.1016/j.cell.2007.11.013 · Cited by 199
Campbell, M. R., Amin, D., & Moasser, M. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1218 · Cited by 188
Dhanasekaran, S. M., Alejandro Balbin, O., Chen, G., Nadal, E., Kalyana-Sundaram, S., Pan, J., Veeneman, B., Cao, X., Malik, R., Vats, P., et al. (2014) · Nature Communications · doi:10.1038/ncomms6893 · Cited by 155
Amin, D. N., Campbell, M. R., & Moasser, M. M. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.08.007 · Cited by 144
Targeting ubiquitin specific proteases for drug discovery
Daviet, L., & Colland, F. (2008) · Biochimie · doi:10.1016/j.biochi.2007.09.013 · Cited by 126
Berlin, I., Schwartz, H., & Nash, P. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016287 · Cited by 121
Regulation of ERBB3/HER3 signaling in cancer
Mujoo, K., Choi, B.-K., Huang, Z., Zhang, N., & An, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.2655 · Cited by 114
Kessler, B. M., & Edelmann, M. J. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9176-6 · Cited by 91
Hamburger, A. W. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9077-5 · Cited by 90
Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia
Black, L. E., Longo, J. F., & Carroll, S. L. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.06.008 · Cited by 82
Panner, A., Crane, C. A., Weng, C., Feletti, A., Fang, S., Parsa, A. T., & Pieper, R. O. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3979 · Cited by 75
Pearson, G. L., Chai, B., Vozheiko, T. D., Liu, X., Kandarpa, M., Piper, R. C., & Soleimanpour, S. A. (2017) · Diabetes · doi:10.2337/db17-0321 · Cited by 77
Lee, S. M., Chin, L.-S., & Li, L. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201204137 · Cited by 69
HER family in cancer progression: From discovery to 2020 and beyond
Kumar, R., George, B., Campbell, M. R., Verma, N., Paul, A. M., Melo-Alvim, C., Ribeiro, L., Pillai, M. R., Costa, L., & Moasser, M. M. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.04.001 · Cited by 70
Wijesuriya, T. M., Ceuninck, L. D., Masschaele, D., Sanderson, M. R., Carias, K. V., Tavernier, J. H., & Wevrick, R. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx311 · Cited by 66
Dai, C., Shi, J., Chen, Y., Iqbal, K., Liu, F., & Gong, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445148 · Cited by 78
Wald, J. H., Hatakeyama, J., Printsev, I., Cuevas-Navarro, A., Fry, W., Saldana, M., VanderVorst, K., Rowson-Hodel, A. R., Angelastro, J. M., Sweeney, C. A., et al. (2017) · Oncogene · doi:10.1038/onc.2017.126 · Cited by 63
Self-citationEmerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
Gaborit, N., Lindzen, M., & Yarden, Y. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1102809 · Cited by 59
Zhang, Y., Zeng, Y., Wang, M., Tian, C., Ma, X., Chen, H., Fang, Q., Jia, L., Du, J., & Li, H. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0157-0 · Cited by 57
Chen, L., Siddiqui, S., Bose, S., Mooso, B. A., Asuncion, A., Bedolla, R. G., Vinall, R. L., Tepper, C. G., Gandour‐Edwards, R. F., Shi, X.-B., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4440 · Cited by 56
Self-citationReciprocal cross-regulation between RNF41 and USP8 controls cytokine receptor sorting and processing
De Ceuninck, L., Wauman, J., Masschaele, D., Peelman, F., & Tavernier, J. (2013) · Journal of Cell Science · doi:10.1242/jcs.131250 · Cited by 52
Regulation of Deubiquitinating Enzymes by Post-Translational Modifications
Das, T., Shin, S. C., Song, E. J., & Kim, E. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114028 · Cited by 59
Quantity Control of the ErbB3 Receptor Tyrosine Kinase at the Endoplasmic Reticulum
Fry, W., Simion, C., Sweeney, C. A., & Carraway, K. L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05105-11 · Cited by 51
Self-citationE3 ubiquitin ligases in ErbB receptor quantity control
Carraway, K. L. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.09.006 · Cited by 45
Self-citationExamination of HER3 targeting in cancer using monoclonal antibodies
Gaborit, N., Abdul‐Hai, A., Mancini, M., Lindzen, M., Lavi, S., Leitner, O., Mounier, L., Chentouf, M., Dunoyer, S., Ghosh, M. S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423645112 · Cited by 49
Revach, O., Sandler, O., Samuels, Y., & Geiger, B. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2316 · Cited by 51
Kelleher, M., Fruhwirth, G. O., Patel, G. S., Ofo, E., Festy, F., Barber, P. R., Ameer‐Beg, S., Vojnovic, B., Gillett, C., Coolen, A. C. C., et al. (2009) · Targeted Oncology · doi:10.1007/s11523-009-0116-y · Cited by 53
Mechanisms of ErbB receptor negative regulation and relevance in cancer
Fry, W., Kotelawala, L., Sweeney, C. A., & Carraway, K. L. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.022 · Cited by 49
Self-citationThe oncoprotein ErbB3 is endocytosed in the absence of added ligand in a clathrin-dependent manner
Sak, M. M., Breen, K., Rønning, S. B., Pedersen, N. M., Bertelsen, V., Stang, E., & Madshus, I. H. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs128 · Cited by 46
Targeting protein quality control pathways in breast cancer
Sannino, S., & Brodsky, J. L. (2017) · BMC Biology · doi:10.1186/s12915-017-0449-4 · Cited by 44
RNF41 orchestrates macrophage-driven fibrosis resolution and hepatic regeneration
Moreno-Lanceta, A., Medrano-Bosch, M., Fundora, Y., Perramón, M., Aspas, J., Parra-Robert, M., Baena, S., Fondevila, C., Edelman, E. R., Jiménez, W., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq6225 · Cited by 42
Lazrek, Y., Dubreuil, O., Garambois, V., Gaborit, N., Larbouret, C., Clorennec, C. L., Thomas, G., Leconet, W., Jarlier, M., Pugnière, M., et al. (2013) · Neoplasia · doi:10.1593/neo.121960 · Cited by 41
Jing, X., Infante, J. L., Nachtman, R. G., & Jurecic, R. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.04.001 · Cited by 37
Mahar, I., Labonté, B., Yogendran, S., Isingrini, E., Perret, L. C., Davoli, M. A., Rachalski, A., Giros, B., Turecki, G., & Mechawar, N. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.132 · Cited by 37
de Goeij, B. E. C. G., Peipp, M., de Haij, S., van den Brink, E. N., Kellner, C., Riedl, T., de Jong, R. N., Vink, T., Strumane, K., Bleeker, W. K., et al. (2014) · mAbs · doi:10.4161/mabs.27705 · Cited by 35
Belleudi, F., Marra, E., Mazzetta, F., Fattore, L., Giovagnoli, M. R., Mancini, R., Aurisicchio, L., Torrisi, M. R., & Ciliberto, G. (2012) · Cell Cycle · doi:10.4161/cc.19861 · Cited by 35
Poovassery, J. S., Kang, J. C., Kim, D., Ober, R. J., & Ward, E. S. (2014) · International Journal of Cancer · doi:10.1002/ijc.29378 · Cited by 35
ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis
Han, J., Shi, X., Zhang, Y., Xu, Y., Jiang, Y., Zhang, C., Li, F., Yang, H., Shang, D., Sun, Z., et al. (2015) · Scientific Reports · doi:10.1038/srep13044 · Cited by 39
Genetics of Cushing’s disease: an update
Perez‐Rivas, L. G., & Reincke, M. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0353-0 · Cited by 35
Luhtala, S., Staff, S. M., Kallioniemi, A. H., Tanner, M., & Isola, J. J. (2018) · BMC Cancer · doi:10.1186/s12885-018-4917-1 · Cited by 32
Barrenschee, M., Lange, C., Cossais, F., Egberts, J.-H., Becker, T., Wedel, T., & Böttner, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00360 · Cited by 28
The E3 ubiquitin ligases regulate inflammation in cardiovascular diseases
Chen, X., Ma, J., Wang, Z. P., & Wang, Z. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.02.008 · Cited by 30
Lee, S. M., Chin, L., & Li, L. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9668-2 · Cited by 28
Deubiquitinases in Ovarian Cancer: Role in Drug Resistance and Tumor Aggressiveness
Beretta, G. L., Costantino, M., Mirra, L., Pettinari, P., & Perego, P. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.100355 · Cited by 28
Censin, J. C., Bovijn, J., Holmes, M. V., & Lindgren, C. M. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00835-8 · Cited by 28
The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer
Modugno, F. D., Mottolese, M., Monte, L. B. D., Trono, P., Balsamo, M., Conidi, A., Melucci, E., Terrenato, I., Belleudi, F., Torrisi, M. R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015852 · Cited by 27
Cai, J., Crotty, T. M., Reichert, E. C., Carraway Kermit, L., Stafforini, D. M., & Topham, M. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.055731 · Cited by 26
Ciardiello, C., Roca, M. S., Noto, A., Bruzzese, F., Moccia, T., Vitagliano, C., Gennaro, E. D., Ciliberto, G., Roscilli, G., Aurisicchio, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7195 · Cited by 27
Clorennec, C. L., Lazrek, Y., Dubreuil, O., Larbouret, C., Poul, M., Mondon, P., Melino, G., Pèlegrin, A., & Chardès, T. (2016) · Oncotarget · doi:10.18632/oncotarget.9455 · Cited by 26
Lewandowski, K. T., & Piwnica-Worms, H. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.129148 · Cited by 24
Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation
Sun, J., Shen, D., Gao, Y., Zheng, Y., Zhao, L., Maa, M., Liu, H., & Chen, X. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s264108 · Cited by 23
HER3 expression and MEK activation in non-small-cell lung carcinoma
Manickavasagar, T., Yuan, W., Carreira, S., Gürel, B., Miranda, S., Ferreira, A., Crespo, M., Riisnaes, R., Baker, C., O'Brien, M. E. R., et al. (2021) · Lung Cancer Management · doi:10.2217/lmt-2020-0031 · Cited by 22
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer
Mizuno, T., Kojima, Y., Yonemori, K., Yoshida, H., Sugiura, Y., Ohtake, Y., Okuma, H. S., Nishikawa, T., Tanioka, M., Sudo, K., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.12200 · Cited by 21
Ingalla, E. Q., Miller, J. K., Wald, J. H., Workman, H. C., Kaur, R. P., Yen, L., Fry, W., Borowsky, A. D., Young, L. J. T., Sweeney, C. A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127977 · Cited by 21
Self-citationTranscription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer
Savoy, R. M., Chen, L., Siddiqui, S., Melgoza, F. U., Durbin-Johnson, B. P., Drake, C., Jathal, M. K., Bose, S., Steele, T. M., Mooso, B. A., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0021 · Cited by 22
Self-citationDeubiquitylating enzymes in receptor endocytosis and trafficking
McCann, A. P., Scott, C. J., Schaeybroeck, S. V., & Burrows, J. F. (2016) · Biochemical Journal · doi:10.1042/bcj20160826 · Cited by 22
RNF41 interacts with the VPS52 subunit of the GARP and EARP complexes
Masschaele, D., Ceuninck, L. D., Wauman, J., Defever, D., Stenner, F., Lievens, S., Peelman, F., & Tavernier, J. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178132 · Cited by 22
Printsev, I., Yen, L., Sweeney, C. A., & Carraway, K. L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.527036 · Cited by 20
Self-citationNovel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancer
Zhang, S., Mukherjee, S., Fan, X., Salameh, A., Mujoo, K., Huang, Z., Li, L., Salazar, G. T., Zhang, N., & An, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.11613 · Cited by 19
The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis
Corno, C., D’Arcy, P., Bagnoli, M., Paolini, B., Costantino, M., Carenini, N., Corna, E., Alberti, P., Mezzanzanica, D., Colombo, D., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1055067 · Cited by 19
Hatakeyama, J., Wald, J. H., Rafidi, H., Cuevas-Navarro, A., Sweeney, C. A., & Carraway, K. L. (2016) · Science Signaling · doi:10.1126/scisignal.aaf1604 · Cited by 19
Self-citationMeijer, I. M. J., Kerperien, J., Sotoca, A. M., van Zoelen, E. J. J., & van Leeuwen, J. E. M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.003 · Cited by 21
Interaction with epsin 1 regulates the constitutive clathrin-dependent internalization of ErbB3
Szymańska, M., Wium, A. M. F., Raiborg, C., Dietrich, M., Liestøl, K., Stang, E., & Bertelsen, V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.011 · Cited by 20
Friend or foe? Reciprocal regulation between E3 ubiquitin ligases and deubiquitinases
Bolhuis, D. L., Emanuele, M. J., & Brown, N. G. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230454 · Cited by 16
Colombo, D., Gatti, L., Sjöstrand, L., Carenini, N., Costantino, M., Corna, E., Arrighetti, N., Zuccolo, M., Cesare, M. D., Linder, S. T., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114900 · Cited by 15
Stindt, S., Cebula, P., Albrecht, U., Keitel, V., Esch, J. S. A., Knoefel, W. T., Bartenschlager, R. F. W., Häussinger, D., & Bode, J. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148711 · Cited by 16
ErbB3 interacts with Hrs and is sorted to lysosomes for degradation
Wium, A. M. F., Dietrich, M., Schink, K. O., Malik, M. S., Rødland, M. S., Bertelsen, V., & Stang, E. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.08.011 · Cited by 13
Deubiquitylating Enzymes in Hepatocellular Carcinoma
Mi, X., Li, Q., Long, G., Pan, Y., Xie, Y., Lu, S., Liang, X., Tang, J., & Zhou, L. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.113193 · Cited by 11
High-Confidence Interactome for RNF41 Built on Multiple Orthogonal Assays
Masschaele, D., Wauman, J., Vandemoortele, G., Sutter, D. D., Ceuninck, L. D., Eyckerman, S., & Tavernier, J. H. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00704 · Cited by 12
Allonby, O., Zawily, A. M. E., Freywald, T., Mousseau, D. D., Chlan, J., Anderson, D. H., Benmerah, A., Sidhu, V. K., Babu, M., DeCoteau, J. F., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.007 · Cited by 11
Steele, T. M., Tsamouri, M. M., Siddiqui, S., Lucchesi, C. A., Vasilatis, D. M., Mooso, B. A., Durbin-Johnson, B. P., Ma, A., Hejazi, N., Parikh, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-36774-1 · Cited by 11
Turowec, J. P., Lau, E. W. T., Wang, X., Brown, K. R., Fellouse, F. A., Jawanda, K. K., Pan, J., Moffat, J., & Sidhu, S. S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004420 · Cited by 9
Pareja, F. G., Pines, G., & Yarden, Y. (2015) · Springer eBooks · doi:10.1007/978-3-319-11888-8_4 · Cited by 10
The retinoic acid derivative, ABPN, inhibits pancreatic cancer through induction of Nrdp1
Byun, S., Shin, S. H., Lee, E., Lee, J., Lee, S., Farrand, L., Jung, S. K., Cho, Y., Um, S., Sin, H., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv148 · Cited by 9
Liu, Y.-W., Wang, Y., Wang, J., Jiang, W., Chen, Y., Shan, J., Li, X., & Wu, X. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.101933 · Cited by 8
Self-citationMaddirevula, S., Anuppalle, M., Huh, T., Kim, S. H., & Rhee, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.025 · Cited by 8
Hayes, D., Kunde, D., Taylor, R. L., Pyecroft, S., Sohal, S. S., & Snow, E. T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177919 · Cited by 9
Protein kinase C regulates ErbB3 turnover
Dietrich, M., Malik, M. S., Rødland, M. S., Bertelsen, V., & Stang, E. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.06.018 · Cited by 8
USP8‐Governed MDA5 Homeostasis Promotes Innate Immunity and Autoimmunity
Zhang, Q., Huang, S., He, Y., Wang, W., Tong, C., Ma, M., Zhao, M., Yi, L., Knobeloch, K., & Zhang, P. (2025) · Advanced Science · doi:10.1002/advs.202503865 · Cited by 7
What is the identity of fibroblast-pneumocyte factor?
King, G., Smith, M. E., Cake, M. H., & Nielsen, H. C. (2016) · Pediatric Research · doi:10.1038/pr.2016.161 · Cited by 7
Estradiol promotes rapid degradation of HER3 in ER-positive breast cancer cell line MCF-7
Suga, J., Izumiyama, K., Tanaka, N., & Saji, S. (2018) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2018.10.008 · Cited by 7
Heregulin Negatively Regulates Transcription of ErbB2/3 Receptors via an AKT‐Mediated Pathway
Awasthi, S., & Hamburger, A. W. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24637 · Cited by 7
Rodrigues‐Junior, D. M., Sáez-Ibáñez, A. R., Scheffler, J. M., Terabayashi, T., Daubel, N., Mäkinen, T., Idevall‐Hagren, O., Moustakas, A., & Ferby, I. (2025) · The Journal of Cell Biology · doi:10.1083/jcb.202501255 · Cited by 6
Mahar, I., Labonté, B., Yogendran, S., Isingrini, E., Perret, L., Davoli, M. A., Rachalski, A., Giros, B., Turecki, G., & Mechawar, N. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.214 · Cited by 7
Zhang, Y., Jin, S. Q., Li, W. X., Gao, G. Q., Zhang, K., & Huang, J. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15028089 · Cited by 5
Role of neuregulin‐1β in dexamethasone‐enhanced surfactant synthesis in fetal type II cells
King, G., Maker, G. L., Berryman, D., Trengove, R. D., & Cake, M. H. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.01.057 · Cited by 5
Song, L., Kong, D., & Yang, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07530-y · Cited by 4
Endocytosis and Endosomal Sorting of Receptor Tyrosine Kinases
Sorkin, A. D., & Fortian, A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2053-2_7 · Cited by 4
Negative regulation of signaling by the EGFR family
Carraway, K. L., Yen, L., Ingalla, E., & Sweeney, C. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-356-1_12 · Cited by 4
Self-citation
Metadata
- Authors
- Cao, Z., Wu, X., Yen, L., Sweeney, C., & Carraway, K. L.
- Affiliations
- UC Davis Comprehensive Cancer Center (US)
- Corresponding author
- Carraway, Kermit L.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2007-03-01
- Volume
- 27
- Issue
- 6
- Pages
- 2180-2188
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC1820496
- OpenAlex
- W2149674434
- Cited by
- 119
- References
- 57
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 8 · 2016: 12 · 2015: 8 · 2014: 12 · 2013: 10 · 2012: 4
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (GM068994, CA118384)
- National Cancer Institute (CA123541, R01CA118384, R01CA123541, CA118384)
- National Institute of General Medical Sciences (R01GM068994, GM068994)
- Topics
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- neuregulin-1, HER3, Nrdp1, USP8, deubiquitinase, protein stability, receptor degradation, E3 ubiquitin ligase, Akt phosphorylation, MCF-7 cells, ubiquitination
- MeSH terms
- Animals, Cell Line, Chlorocebus aethiops, Humans, Endopeptidases, Phosphothreonine, Protein Binding, Signal Transduction, Down-Regulation, Phosphatidylinositol 3-Kinases, Neuregulin-1, Receptor, ErbB-3, Ubiquitin, Ubiquitin Thiolesterase, Ubiquitin-Protein Ligases, Proto-Oncogene Proteins c-akt, Endosomal Sorting Complexes Required for Transport
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.